SEC Comment Letter 0000000000-24-004610 to Renalytix plc (RNLX, RTNXF) (CIK 0001811115) (RENXF)
Renalytix plc (RNLX, RTNXF) (CIK 0001811115)
Date: April 25, 2024 · CIK: 0001811115 · Accession: 0000000000-24-004610
AI Filing Summary & Sentiment
File numbers found in text: 333-278765
Letter
United States securities and exchange commission logo April 25, 2024 James McCullough Chief Executive Officer and Director Renalytix plc 2 Leman Street London E1W 9US United Kingdom Re:Renalytix plc Registration Statement on Form S-3 Filed April 17, 2024 File No. 333-278765 Dear James McCullough: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Katie Kazen
Show Raw Text
United States securities and exchange commission logo
April 25, 2024
James McCullough
Chief Executive Officer and Director
Renalytix plc
2 Leman Street
London E1W 9US
United Kingdom
Re:Renalytix plc
Registration Statement on Form S-3
Filed April 17, 2024
File No. 333-278765
Dear James McCullough:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Katie Kazen